BSX vs KINS · P/E 20, rev $10.65B vs P/E 6.8, rev $125.6M
Boston Scientific Corp (BSX) versus Kingstone Companies Inc (KINS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Kingstone Companies Inc (KINS) is a insurance - property & casualty company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported KINS revenue for 2026-06-30 was $125.6M. Net income was $9.7M. KINS currently screens at market cap $217.9M and trailing P/E 6.8.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. KINS currently screens at market cap $217.9M and trailing P/E 6.8.
Not investment advice. Open the BSX and KINS stock pages for the full models.
Not investment advice.